JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 125 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,406 | +8.7% | 168,424 | -3.3% | 0.03% | +16.0% |
| Q3 2021 | $1,294 | -46.8% | 174,175 | -51.3% | 0.02% | -44.4% |
| Q2 2021 | $2,433 | -30.1% | 357,817 | +5.6% | 0.04% | -39.2% |
| Q1 2021 | $3,481 | +24.3% | 338,969 | -15.3% | 0.07% | +17.5% |
| Q4 2020 | $2,800 | -27.2% | 400,013 | -15.2% | 0.06% | -51.9% |
| Q3 2020 | $3,848 | +8.1% | 471,622 | -8.6% | 0.13% | +1.6% |
| Q2 2020 | $3,559 | +183.6% | 515,748 | +95.3% | 0.13% | +89.7% |
| Q1 2020 | $1,255 | +17.5% | 264,139 | +116.0% | 0.07% | +38.8% |
| Q4 2019 | $1,068 | +161.1% | 122,282 | -0.5% | 0.05% | +113.0% |
| Q3 2019 | $409 | -28.9% | 122,912 | +5.9% | 0.02% | -17.9% |
| Q2 2019 | $575 | -26.1% | 116,080 | -7.5% | 0.03% | -33.3% |
| Q1 2019 | $778 | +75.6% | 125,533 | -4.5% | 0.04% | +35.5% |
| Q4 2018 | $443 | -49.6% | 131,393 | -2.9% | 0.03% | -35.4% |
| Q3 2018 | $879 | -12.8% | 135,280 | +2.8% | 0.05% | -21.3% |
| Q2 2018 | $1,008 | -62.6% | 131,592 | +9.1% | 0.06% | -68.7% |
| Q1 2018 | $2,695 | +79.1% | 120,585 | +2.1% | 0.20% | +65.3% |
| Q4 2017 | $1,505 | – | 118,060 | – | 0.12% | – |
Download | ||||||